LifeStance Health GroupLFST -1.62%56 Earnings Yield (Joel Greenblatt) % is 1.61% as of Mar. 2026. GuruFocus rates LFST with a GF Score™ of 56/100 and a GF Value™ of $8.25 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 683 Healthcare Providers & Services companies, LifeStance Health Group ranks worse than 62.08% on this metric.
LifeStance Health Group's Enterprise Value for the quarter that ended in Mar. 2026 was $2,734 Mil.
LifeStance Health Group's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was $44 Mil. LifeStance Health Group's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2026 was 1.61%.
The historical rank and industry rank for LifeStance Health Group's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
LFST'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -18.8 Med: -5.17 Max: 1.6
Current: 0.96
During the past 7 years, the highest Earnings Yield (Joel Greenblatt) of LifeStance Health Group was 1.60%. The lowest was -18.80%. And the median was -5.17%.
LFST's Earnings Yield (Joel Greenblatt) % is ranked worse than 62.08% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 3.33
vs LFST: 0.96
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. LifeStance Health Group's Forward Rate of Return (Yacktman) % for the quarter that ended in Mar. 2026 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
LifeStance Health Group (NAS:LFST) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
LifeStance Health Group Earnings Yield (Joel Greenblatt) % Related Terms
LifeStance Health Group Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for LifeStance Health Group's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LifeStance Health Group Earnings Yield (Joel Greenblatt) % Chart
For the Medical Care Facilities subindustry, LifeStance Health Group's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeStance Health Group Earnings Yield (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LifeStance Health Group's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where LifeStance Health Group's Earnings Yield (Joel Greenblatt) % falls into.
LifeStance Health Group Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
LifeStance Health Groups Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2025 is calculated as
LifeStance Health Group's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $44 Mil.
What does a Earnings Yield (Joel Greenblatt) % of 1.61% mean?
LifeStance Health Group (LFST) has a Earnings Yield (Joel Greenblatt) % of 1.61% as of Mar. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on LifeStance Health Group and its competitors. According to the industry distribution chart, LifeStance Health Group ranks #424 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 62.1%.
Is LifeStance Health Group's Earnings Yield (Joel Greenblatt) % too high?
LifeStance Health Group's current Earnings Yield (Joel Greenblatt) % is 1.61%. The Healthcare Providers & Services industry median Earnings Yield (Joel Greenblatt) % is 3.33. LifeStance Health Group's value of 1.61% is 51.7% below this industry median. Based on the distribution chart, LifeStance Health Group ranks #424 out of 683 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, LifeStance Health Group has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LifeStance Health Group's Earnings Yield (Joel Greenblatt) % compare to CON and BKD?
According to the Healthcare Providers & Services industry distribution chart, LifeStance Health Group ranks #424 out of 683 companies for Earnings Yield (Joel Greenblatt) %. This places LifeStance Health Group in the lower half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 3.33. LifeStance Health Group's value of 1.61% is 51.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median Earnings Yield (Joel Greenblatt) % among Healthcare Providers & Services companies is 3.33, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LifeStance Health Group's current Earnings Yield (Joel Greenblatt) % of 1.61% is 51.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on LifeStance Health Group and its competitors. For the Healthcare Providers & Services industry, the median Earnings Yield (Joel Greenblatt) % is 3.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LifeStance Health Group's current Earnings Yield (Joel Greenblatt) % is 1.61%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeStance Health Group stock overvalued right now?
Based on GuruFocus' analysis, LifeStance Health Group (LFST) is currently considered Significantly Overvalued. The stock's GF Value™ is $8.25, compared to a current price of $11.26 — trading 36.4% above its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 1.61% and 51.7% below the Healthcare Providers & Services industry median of 3.33. LifeStance Health Group's overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For LifeStance Health Group (LFST), the current Earnings Yield (Joel Greenblatt) % is 1.61% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeStance Health Group (LFST) Overvalued in 2026?
Based on GuruFocus' analysis, LifeStance Health Group stock appears to be overvalued.
The current stock price of $11.26 is trading 36.4% above its estimated GF Value™ of $8.25.
GuruFocus considers LifeStance Health Group to be Significantly Overvalued.
Key valuation signals for LFST:
Earnings Yield (Joel Greenblatt) %: 1.61%
GF Value™: $8.25 vs. price of $11.26 (36.4% above fair value)
Industry Position: 51.7% below the Healthcare Providers & Services median (#424 of 683)
No single metric tells the full story. See the LFST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
56GF Score
Get the complete analysis for LFST
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LFST has been successfully added to your 
